课题基金 / 基金详情

Pathophysiological and Logical Clinical Study in patients with Sarcoidosm Prognoitic factors

Pathophysiological and Logical Clinical Study in patients with Sarcoidosm Prognoitic factors
结节病患者的病理生理学和逻辑临床研究 预后因素
批准号:
08670661
负责人:
NAGAI Sonoko
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

NAGAI Sonoko的其他基金

相似基金

相关文献

中文摘要
翻译
我们试图评估结节病患者的远期预后和预后因素。自发性消退和慢性化是肺结节病患者的两个特征命运。我们确实将胸片上发现阴影5年后的病例判断为慢性病例,但没有明确的参数来帮助我们预测慢性是否会进展为纤维化。总体而言,根据868例肺部肉芽肿病患者的自身经验,6%的无症状患者和12%的有症状的护理人员在发现异常阴影10年后出现恶化。除了几个预后因素(发现时的年龄、是否有实质性病变、有无激素治疗史)、胸外病变的存在外,大眼支气管肺泡灌洗液中活化的维生素D、血管紧张素II受体基因、IL-I受体拮抗剂/IL-β比率似乎是结节病的良好预后因素。
英文摘要
We tried to evaluate long-term prognosis and prognostic factors of patients with sarcoidosis. Spontaneous regression and chronicity are two characteristic fates in patients with pulmonary sarcoidosis.We did judge the cases with 5 years after detection of the shadows on chest radiographs as chronic cases, but there are no definite parameters to help us predict if a chronicity will progress into fibrosis. Overall, based on own experiences of 868 patients with pulmonary, Sarwidosis, 6% of the asymptomatic patients and 12% of the symptomatic cares showed deterioration more them 10 years after detection of the abnormal shadows.In addition to several prognostic factors (age at the detection, presence of parenchymal lesions, and prerious history of treatment with corticosteroids, the presence of extrathoracie involvements), activated vitamin D, angiotencin II receptor gene, IL-I receptor antagonist/IL-β ration in BALF macrophoye seemed to be good prognostic factors of sarcoidosis.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Takeshi Mikuniya: "Quantitative Evaluation of the IL-1β nad IL-1 receptor antagonist obtained from BALF macrophagas in patients with Interstitial Lung Diseases"Sarcoidosis Vasculitis and Diffuse Lung Diseases. 14. 39-45 (1997)
Takeshi Mikuniya:“从间质性肺病患者的 BALF 巨噬细胞中获得的 IL-1β 和 IL-1 受体拮抗剂的定量评估”结节病血管炎和弥漫性肺病 14. 39-45 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Michio Sigematsu: "Summer-type Hypersensitivity Pneumonitis,T-cell Receptor V Gene Usage in BALF T-cells from 3 Cases in One Family"Sarcoidosis Vasculitis and Diffuse Lung Diseases. 15. 173-177 (1998)
Michio Sigematsu:“夏季型过敏性肺炎,一个家族 3 例 BALF T 细胞中 T 细胞受体 V 基因的使用”结节病性血管炎和弥漫性肺病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sonoko Nagai: "Bronchoclreclar Lavage : Still useful in diagnosing Sarcoiclorin?" Clinics in Chest Medicine. 18・4. 787-797 (1997)
Sonoko Nagai:“Bronchoclerclar Lavage:在诊断肌氯蛋白方面仍然有用吗?”Clinics in Chest Medicine 18・4 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Michio Shigematsu: "Summer-type Hyperserisitivity Pneumonitis.T-cell Recepton V Bene Usage in BALF T-cells from 3 Coses in One Family" Sarcoidosm Vasculitis and Diffuse Lung Disecses. 15. 173-177 (1998)
Michio Shigematsu:“夏季型高过敏性肺炎。T 细胞受体 V Bene 在来自 3 个家族的 BALF T 细胞中的使用”结节性血管炎和弥漫性肺疾病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 33 条
    Protective mechanisms in inflammatory lung diseases at airway and alveolar area
    • 批准号:
      12670557
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      2000
    • 负责人:
      NAGAI Sonoko
    • 依托单位:
    Inflammation and Fibrosis in patients with Interstitial Pneumonia
    • 批准号:
      10670540
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1998
    • 负责人:
      NAGAI Sonoko
    • 依托单位:
    Multifactorial analysis of chronicity and pathogenesis in patients with sarcoidosis
    • 批准号:
      06670610
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      NAGAI Sonoko
    • 依托单位:
    Characterization of IL-1 inhibitor released from alveolar macrophage and evaluation of chronic inflammation in lungs.
    • 批准号:
      03670399
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1991
    • 负责人:
      NAGAI Sonoko
    • 依托单位:
    海外基金